Hong Chang, MD, PhD, FRCPC

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI)
Keywords: myeloma, molecular cytogenetics, prognostic factors, small molecule inhibitors

Dr. Chang's research focuses on molecular pathogenesis and biomarkers as well as therapeutic targets in multiple myeloma and acute leukemias.

For a list of Dr. Chang's publications, please visit PubMed or Scopus.
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI)

Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto.